News

The facility will now include reactor vessels with clean room product isolation and drying equipment to allow Highly Potent API manufacture up to 600kg batch size. The expansion,

Immunologix has developed mAbLogix platform, which enables the ability to derive fully human antibodies. The antibodies target all antigen types including, cancer cells, viruses, bacteria, toxins, as well

The entire transaction will amount to $415m. As per the deal, Cubist will purchase all of the outstanding shares of Adolor for the upfront cash payment and a

Dulera Inhalation Aerosol, which is used to treat asthma combines mometasone furoate, an inhaled corticosteroid, and formoterol fumarate, a long-acting beta2-agonist. The two 26-week, multicenter, double-blind, placebo controlled

Diethylpropion HCl, like many anti-obesity drugs, is primarily sold to bariatric clinics, the company said. Lannett president and CEO Arthur P Bedrosian said the approval would add to

Genzyme will incorporate the Rare Disease business and the Multiple Sclerosis franchise, under the leadership of the new CEO, the company said. David joined Genzyme in 1994 as

AIN457 is a fully human, targeted monoclonal antibody that specifically binds to and neutralizes interleukin-17A (IL-17A), an inflammatory cytokine implicated in many immune-mediated diseases, including psoriasis. The three

TermManager, a code set management and collaborative mapping application, supports healthcare data interoperability initiatives by enabling widespread access to national healthcare vocabulary standards including SNOMED CT, LOINC, ICD,

Both the companies offer services in regulatory affairs, Phase I-IV clinical trial management, and clinical trial site management in China. As part of the acquisition, MedKey/Jiecheng will increase